• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性深入分析肝糖原贮积病患者的连续血糖监测数据集:葡萄糖管理的推荐结局参数。

A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management.

机构信息

Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

enerGQ BV, Groningen, The Netherlands.

出版信息

J Inherit Metab Dis. 2021 Sep;44(5):1136-1150. doi: 10.1002/jimd.12383. Epub 2021 May 5.

DOI:10.1002/jimd.12383
PMID:33834518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8519135/
Abstract

Continuous glucose monitoring (CGM) systems have great potential for real-time assessment of glycemic variation in patients with hepatic glycogen storage disease (GSD). However, detailed descriptions and in-depth analysis of CGM data from hepatic GSD patients during interventions are scarce. This is a retrospective in-depth analysis of CGM parameters, acquired in a continuous, real-time fashion describing glucose management in 15 individual GSD patients. CGM subsets are obtained both in-hospital and at home, upon nocturnal dietary intervention (n = 1), starch loads (n = 11) and treatment of GSD Ib patients with empagliflozin (n = 3). Descriptive CGM parameters, and parameters reflecting glycemic variation and glycemic control are considered useful CGM outcome parameters. Furthermore, the combination of first and second order derivatives, cumulative sum and Fourier analysis identified both subtle and sudden changes in glucose management; hence, aiding assessment of dietary and medical interventions. CGM data interpolation for nocturnal intervals reduced confounding by physical activity and diet. Based on these analyses, we conclude that in-depth CGM analysis can be a powerful tool to assess glucose management and optimize treatment in individual hepatic GSD patients.

摘要

连续血糖监测 (CGM) 系统在实时评估肝糖原贮积病 (GSD) 患者的血糖变化方面具有巨大潜力。然而,对于肝 GSD 患者在干预期间的 CGM 数据的详细描述和深入分析却很少。这是对 15 名 GSD 患者的 CGM 参数进行回顾性深入分析,以连续、实时的方式描述血糖管理。CGM 子集是在住院期间和在家中获得的,包括夜间饮食干预 (n=1)、淀粉负荷 (n=11) 和用恩格列净治疗 GSD Ib 患者 (n=3)。描述性 CGM 参数以及反映血糖变化和血糖控制的参数被认为是有用的 CGM 结果参数。此外,一阶和二阶导数、累积和傅里叶分析的组合可以识别出血糖管理中的细微和突然变化,从而有助于评估饮食和医疗干预措施。夜间间隔的 CGM 数据内插可减少运动和饮食带来的混杂因素。基于这些分析,我们得出结论,深入的 CGM 分析可以成为评估个体肝 GSD 患者血糖管理和优化治疗的有力工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2765/8519135/4aa8b8c59b0f/JIMD-44-1136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2765/8519135/22851ae57d47/JIMD-44-1136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2765/8519135/4aa8b8c59b0f/JIMD-44-1136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2765/8519135/22851ae57d47/JIMD-44-1136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2765/8519135/4aa8b8c59b0f/JIMD-44-1136-g001.jpg

相似文献

1
A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management.回顾性深入分析肝糖原贮积病患者的连续血糖监测数据集:葡萄糖管理的推荐结局参数。
J Inherit Metab Dis. 2021 Sep;44(5):1136-1150. doi: 10.1002/jimd.12383. Epub 2021 May 5.
2
Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study.肝糖原贮积病和特发性酮性低血糖患者的连续血糖监测指标:一项单中心、回顾性、观察性研究。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108573. doi: 10.1016/j.ymgme.2024.108573. Epub 2024 Aug 30.
3
A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.糖原贮积病 Ia 型连续血糖监测的前瞻性研究:走向血糖目标
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3612-e3623. doi: 10.1210/clinem/dgac411.
4
[The application of continuous glucose monitoring in the management of hepatic glycogen storage disease].[动态血糖监测在肝糖原累积症管理中的应用]
Zhonghua Er Ke Za Zhi. 2021 Jun 2;59(6):452-458. doi: 10.3760/cma.j.cn112140-20210321-00235.
5
The use of continuous glucose monitoring in the practical management of glycogen storage disorders.连续血糖监测在糖原贮积症实际管理中的应用。
J Inherit Metab Dis. 2011 Jun;34(3):631-42. doi: 10.1007/s10545-011-9335-3. Epub 2011 May 10.
6
Continuous glucose monitoring in children with glycogen storage disease type I.儿童糖原贮积病Ⅰ型的连续血糖监测。
Eur J Clin Nutr. 2014 Jan;68(1):101-5. doi: 10.1038/ejcn.2013.186. Epub 2013 Oct 23.
7
Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.血糖控制与糖原贮积症 I 型的并发症:来自瑞士注册研究的结果。
Mol Genet Metab. 2019 Apr;126(4):355-361. doi: 10.1016/j.ymgme.2019.02.008. Epub 2019 Feb 28.
8
A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring.远程医疗在肝糖原贮积病患者及其医护人员中的初步研究:从床边到家庭站点监测。
J Inherit Metab Dis. 2018 Nov;41(6):929-936. doi: 10.1007/s10545-018-0167-2. Epub 2018 Mar 29.
9
Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.妊娠期使用连续血糖监测的 1 型糖尿病女性的血糖、母婴结局 - 泵 vs 多次每日注射:一项观察性队列研究的二次分析。
Acta Obstet Gynecol Scand. 2021 May;100(5):927-933. doi: 10.1111/aogs.14039. Epub 2021 Jan 12.
10
Real-life utilization of real-time continuous glucose monitoring: the complete picture.实时连续血糖监测在实际生活中的应用:全貌
J Diabetes Sci Technol. 2011 Jul 1;5(4):860-70. doi: 10.1177/193229681100500407.

引用本文的文献

1
Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia.两名患有Ia型糖原贮积病和先兆子痫患者的胎盘病理学
JIMD Rep. 2025 Jun 12;66(4):e70025. doi: 10.1002/jmd2.70025. eCollection 2025 Jul.
2
Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.了解IX型糖原贮积病:一项以临床为重点的系统评价——为何它并非良性且需要警惕。
Genes (Basel). 2025 May 15;16(5):584. doi: 10.3390/genes16050584.
3
State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases.

本文引用的文献

1
The Diabits App for Smartphone-Assisted Predictive Monitoring of Glycemia in Patients With Diabetes: Retrospective Observational Study.用于糖尿病患者血糖智能手机辅助预测监测的Diabits应用程序:回顾性观察研究。
JMIR Diabetes. 2020 Sep 22;5(3):e18660. doi: 10.2196/18660.
2
The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases.尿葡萄糖四糖作为肝糖原贮积病患者生物标志物的多面性
Genet Med. 2020 Nov;22(11):1915-1916. doi: 10.1038/s41436-020-0878-2. Epub 2020 Jul 13.
3
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
医疗服务提供者、患者及护理人员关于肝糖原贮积病连续血糖监测的最新技术水平与共识声明
J Inherit Metab Dis. 2025 May;48(3):e70040. doi: 10.1002/jimd.70040.
4
A deep learning approach for blood glucose monitoring and hypoglycemia prediction in glycogen storage disease.一种用于糖原贮积病血糖监测和低血糖预测的深度学习方法。
Sci Rep. 2025 Apr 15;15(1):13032. doi: 10.1038/s41598-025-97391-8.
5
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa).AAV8介导的肝脏定向基因疗法DTX401在1a型糖原贮积病(GSDIa)成人患者中的安全性和有效性。
J Inherit Metab Dis. 2025 Mar;48(2):e70014. doi: 10.1002/jimd.70014.
6
Impact of Flash Glucose Monitoring in Adults with Inherited Metabolic Disorders at Risk of Hypoglycemia.实时葡萄糖监测对有低血糖风险的遗传性代谢紊乱成年患者的影响。
Nutrients. 2025 Jan 9;17(2):222. doi: 10.3390/nu17020222.
7
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications.遗传性代谢紊乱患者低血糖风险的连续血糖监测及其营养影响。
Rev Endocr Metab Disord. 2024 Oct;25(5):897-910. doi: 10.1007/s11154-024-09903-y. Epub 2024 Oct 1.
8
Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.延长释放型玉米淀粉在肝糖原贮积病中的短期和长期可接受性和疗效:Glyde 研究结果。
Orphanet J Rare Dis. 2024 Jul 9;19(1):258. doi: 10.1186/s13023-024-03274-y.
9
Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review.达格列净和恩格列净在儿科适应证中的应用:系统评价。
Paediatr Drugs. 2024 May;26(3):229-243. doi: 10.1007/s40272-024-00623-z. Epub 2024 Apr 18.
10
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care.内分泌系统在肝糖原贮积病中的作用:病理生理学及对治疗的意义
Rev Endocr Metab Disord. 2024 Aug;25(4):707-725. doi: 10.1007/s11154-024-09880-2. Epub 2024 Apr 1.
用 SGLT2 抑制剂治疗糖原贮积病 Ib 型的中性粒细胞减少症和中性粒细胞功能障碍。
Blood. 2020 Aug 27;136(9):1033-1043. doi: 10.1182/blood.2019004465.
4
A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach.一套标准的以患者为中心的糖尿病结局评估指标:国际统一方法的研究结果。
Diabet Med. 2020 Dec;37(12):2009-2018. doi: 10.1111/dme.14286. Epub 2020 Mar 20.
5
Introduction: .引言:.
Diabetes Care. 2020 Jan;43(Suppl 1):S1-S2. doi: 10.2337/dc20-Sint.
6
Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance.肝糖原贮积病的研究重点:与詹姆斯·林德联盟的国际优先事项确定合作项目
J Inherit Metab Dis. 2020 Mar;43(2):279-289. doi: 10.1002/jimd.12178. Epub 2019 Nov 13.
7
A New Era for Rare Genetic Diseases: Messenger RNA Therapy.罕见遗传病的新纪元:信使 RNA 疗法。
Hum Gene Ther. 2019 Oct;30(10):1180-1189. doi: 10.1089/hum.2019.090. Epub 2019 Jul 1.
8
Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes.数据驱动的血糖模式分类与异常检测:机器学习在1型糖尿病中的应用
J Med Internet Res. 2019 May 1;21(5):e11030. doi: 10.2196/11030.
9
Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.不同血糖控制水平的 2 型糖尿病患者中,血糖变异性与主要不良心血管结局及低血糖风险的相关性及其预后意义。
Endocrine. 2019 Jun;64(3):536-543. doi: 10.1007/s12020-019-01893-1. Epub 2019 Mar 13.
10
Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.血糖控制与糖原贮积症 I 型的并发症:来自瑞士注册研究的结果。
Mol Genet Metab. 2019 Apr;126(4):355-361. doi: 10.1016/j.ymgme.2019.02.008. Epub 2019 Feb 28.